Selected research
Industry Research
Propofol Injection Industry Research Report 2026
Market perspective
The global Propofol Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Propofol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Propofol Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Propofol Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Propofol Injection include Pfizer, B. Braun Medical, AstraZeneca, Wellona Pharma, Rusoma Laboratories, Neon Laboratories Limited, Fresenius Kabi and Centurion Healthcare Private Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Propofol Injection market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Propofol Injection Market by Company
Pfizer
B. Braun Medical
AstraZeneca
Wellona Pharma
Rusoma Laboratories
Neon Laboratories Limited
Fresenius Kabi
Centurion Healthcare Private Limited
Propofol Injection Segment by Type
Propofol Medium/Long Chain Fat Emulsion Injection
Propofol Emulsion Injection
Propofol Injection Segment by Application
Hospital
Clinic
Other
Propofol Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Propofol Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Propofol Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Propofol Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Propofol Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Propofol Medium/Long Chain Fat Emulsion Injection
- Propofol Emulsion Injection
Applications
- Hospital
- Clinic
- Other
Companies covered
- Pfizer
- B. Braun Medical
- AstraZeneca
- Wellona Pharma
- Rusoma Laboratories
- Neon Laboratories Limited
- Fresenius Kabi
- Centurion Healthcare Private Limited
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Propofol Injection Market Size (2021-2032)
- 2.2.2 Global Propofol Injection Sales (2021-2032)
- 2.2.3 Global Propofol Injection Market Average Price (2021-2032)
- 2.3 Propofol Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Propofol Medium/Long Chain Fat Emulsion Injection
- 2.3.3 Propofol Emulsion Injection
- 2.4 Propofol Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Propofol Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Propofol Injection Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Propofol Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Propofol Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Propofol Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Propofol Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Propofol Injection, Product Type & Application
- 3.8 Global Manufacturers of Propofol Injection, Established Date
- 3.9 Global Propofol Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pfizer
- 4.1.1 Pfizer Company Information
- 4.1.2 Pfizer Business Overview
- 4.1.3 Pfizer Propofol Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pfizer Propofol Injection Product Portfolio
- 4.1.5 Pfizer Recent Developments
- 4.2 B. Braun Medical
- 4.2.1 B. Braun Medical Company Information
- 4.2.2 B. Braun Medical Business Overview
- 4.2.3 B. Braun Medical Propofol Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 B. Braun Medical Propofol Injection Product Portfolio
- 4.2.5 B. Braun Medical Recent Developments
- 4.3 AstraZeneca
- 4.3.1 AstraZeneca Company Information
- 4.3.2 AstraZeneca Business Overview
- 4.3.3 AstraZeneca Propofol Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 AstraZeneca Propofol Injection Product Portfolio
- 4.3.5 AstraZeneca Recent Developments
- 4.4 Wellona Pharma
- 4.4.1 Wellona Pharma Company Information
- 4.4.2 Wellona Pharma Business Overview
- 4.4.3 Wellona Pharma Propofol Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Wellona Pharma Propofol Injection Product Portfolio
- 4.4.5 Wellona Pharma Recent Developments
- 4.5 Rusoma Laboratories
- 4.5.1 Rusoma Laboratories Company Information
- 4.5.2 Rusoma Laboratories Business Overview
- 4.5.3 Rusoma Laboratories Propofol Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Rusoma Laboratories Propofol Injection Product Portfolio
- 4.5.5 Rusoma Laboratories Recent Developments
- 4.6 Neon Laboratories Limited
- 4.6.1 Neon Laboratories Limited Company Information
- 4.6.2 Neon Laboratories Limited Business Overview
- 4.6.3 Neon Laboratories Limited Propofol Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Neon Laboratories Limited Propofol Injection Product Portfolio
- 4.6.5 Neon Laboratories Limited Recent Developments
- 4.7 Fresenius Kabi
- 4.7.1 Fresenius Kabi Company Information
- 4.7.2 Fresenius Kabi Business Overview
- 4.7.3 Fresenius Kabi Propofol Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Fresenius Kabi Propofol Injection Product Portfolio
- 4.7.5 Fresenius Kabi Recent Developments
- 4.8 Centurion Healthcare Private Limited
- 4.8.1 Centurion Healthcare Private Limited Company Information
- 4.8.2 Centurion Healthcare Private Limited Business Overview
- 4.8.3 Centurion Healthcare Private Limited Propofol Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Centurion Healthcare Private Limited Propofol Injection Product Portfolio
- 4.8.5 Centurion Healthcare Private Limited Recent Developments
5 Global Propofol Injection Market Scenario by Region
- 5.1 Global Propofol Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Propofol Injection Sales by Region: 2021-2032
- 5.2.1 Global Propofol Injection Sales by Region: 2021-2026
- 5.2.2 Global Propofol Injection Sales by Region: 2027-2032
- 5.3 Global Propofol Injection Revenue by Region: 2021-2032
- 5.3.1 Global Propofol Injection Revenue by Region: 2021-2026
- 5.3.2 Global Propofol Injection Revenue by Region: 2027-2032
- 5.4 North America Propofol Injection Market Facts & Figures by Country
- 5.4.1 North America Propofol Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Propofol Injection Sales by Country (2021-2032)
- 5.4.3 North America Propofol Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Propofol Injection Market Facts & Figures by Country
- 5.5.1 Europe Propofol Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Propofol Injection Sales by Country (2021-2032)
- 5.5.3 Europe Propofol Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Propofol Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Propofol Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Propofol Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Propofol Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Propofol Injection Market Facts & Figures by Country
- 5.7.1 South America Propofol Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Propofol Injection Sales by Country (2021-2032)
- 5.7.3 South America Propofol Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Propofol Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Propofol Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Propofol Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Propofol Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Propofol Injection Sales by Type (2021-2032)
- 6.1.1 Global Propofol Injection Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Propofol Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Propofol Injection Revenue by Type (2021-2032)
- 6.2.1 Global Propofol Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Propofol Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Propofol Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Propofol Injection Sales by Application (2021-2032)
- 7.1.1 Global Propofol Injection Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Propofol Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Propofol Injection Revenue by Application (2021-2032)
- 7.2.1 Global Propofol Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Propofol Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Propofol Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Propofol Injection Value Chain Analysis
- 8.1.1 Propofol Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Propofol Injection Production Mode & Process
- 8.2 Propofol Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Propofol Injection Distributors
- 8.2.3 Propofol Injection Customers
9 Global Propofol Injection Analyzing Market Dynamics
- 9.1 Propofol Injection Industry Trends
- 9.2 Propofol Injection Industry Drivers
- 9.3 Propofol Injection Industry Opportunities and Challenges
- 9.4 Propofol Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst